Ketao Lan

Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer

Keke Nie, Zhongfa Zhang, Chunling Zhang et al. · Lung Cancer · 2018 · 50 citations

Egfr T790m, Non-small-cell Lung Cancer, Medicine +8

Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients

Keke Nie, Haiping Jiang, Chunling Zhang et al. · BioMed Research International · 2018 · 35 citations · Full text

IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation

Xiaofeng Mu, Qi Zhao, Wen Chen et al. · Frontiers in Oncology · 2021 · 25 citations · Full text

M6a Methylation, Cancer Immunosurveillance, Oncogenic Agent +13

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Youxin Ji, Zhongfa Zhang, Ketao Lan et al. · Chinese Medical Sciences Journal · 2014 · 17 citations

Blood transfusion and mortality in myocardial infarction: an updated meta-analysis

Yin Zuo-min, Botao Yu, Weisheng Liu et al. · Oncotarget · 2017 · 11 citations · Full text